Illumina ( (ILMN) ) just unveiled an announcement.

Illumina, Inc. (NASDAQ: ILMN) today announced changes to its Board of Directors. Frances Arnold, PhD, Robert S. Epstein, MD, and Gary S. Guthart, PhD, will retire from the Board in connection with the ...

Illumina, Inc. (NASDAQ: ILMN) and Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced an expanded collaboration to advance precision oncology ...

We recently compiled a list of the 10 Best Immunotherapy Stocks to Buy Now. In this article, we are going to take a look at where Illumina, Inc. (NASDAQ:ILMN) stands against the other immunotherapy ...

SAN DIEGO, June 23, 2025 /PRNewswire/ -- Illumina, Inc. (ILMN) announced today it has entered into a definitive agreement with Standard BioTools (LAB) under which Illumina will acquire SomaLogic, a ...

Expands pharma access to large omics datasets to advance target discovery and drug development SAN DIEGO, Oct. 1, 2025 /PRNewswire/ -- Illumina, Inc. (ILMN) today announced the launch of BioInsight, a ...

Diamond Hill Capital, an investment management company, released its “Mid Cap Strategy” investor letter for the first quarter of 2025. A copy of the letter can be downloaded here. The first quarter of ...

Illumina, Inc. ILMN is set to release fourth-quarter 2025 results on Feb. 5, after the closing bell. The company posted adjusted earnings per share (EPS) of $1.34 in the last reported quarter, which ...

Illumina Inc. (NASDAQ:ILMN) has agreed to pay $9.8 million to resolve allegations it knowingly sold genomic sequencing systems with cybersecurity vulnerabilities to several U.S. government agencies.

Investors in Illumina Inc (Symbol: ILMN) saw new options become available today, for the May 9th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ILMN options ...

Illumina Inc. was hit with an antitrust lawsuit on Sept. 22 in California Northern District Court over alleged anticompetitive practices in the DNA sequencing market. The action, brought by Quinn ...